Artwork

内容由The Bonnell Foundation and Laura Bonnell提供。所有播客内容(包括剧集、图形和播客描述)均由 The Bonnell Foundation and Laura Bonnell 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Touraj Manshadi falling through the gaps in health policy

36:41
 
分享
 

Manage episode 445063602 series 2902409
内容由The Bonnell Foundation and Laura Bonnell提供。所有播客内容(包括剧集、图形和播客描述)均由 The Bonnell Foundation and Laura Bonnell 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

We’re in Canada for this podcast. Canadian Advocate Beth Vanstone has two daughters, one with CF and she’s hosting this podcast with Laura Bonnell.

Beth is introducing us to 32-year-old To Touraj Dehghan Manshadi who has a CF mutation that is common to Iran, but rare in Canada where he lives. You may be surprised to learn Canada does not have a rare disease strategy. We know American’s thinking that medically everything is better in Canada, but that’s not true. Many countries around the globe are struggling with the high cost of drugs for Rare Diseases, Canada is no exception. However, while we see industrialized countries around world looking at solutions to get rare therapies to patients quickly in an effort to maintain, improve and save lives, Canada remains stuck relying on a drug system designed to handle aspirin. Canada is the only country in the G7 without a national approach to rare diseases.

In February 2023 the Federal government announced a Rare Disease Drug Strategy with a 1.4 billion budget over three yrs to support it. The expectation was that drugs for rare diseases would have a quicker pathway and that it would address the specific challenges of the rare community and fill some of the many gaps to access. Sadly, that has not been the case thus far.

Beth says, “There are a lot of challenges for patients, it’s very timely, there are a lot of gaps that will potentially harm patients.” Touraj is one of the patients falling through the gaps.

Touraj says his FEV1 is 35 percent, which means he is potentially looking at a double lung transplant. “It is shocking that in the next two to three years I might be getting to the point of needing a transplant. We’re sad about it. My girlfriend is sadder about it than I am right now. I think of it as more of a reality.” The hope would be access to a drug, despite his rare mutation, but the ability to try it.

To connect with Touraj

Instagram: https://www.instagram.com/tojyla/

Facebook: https://www.facebook.com/touraj.dehghan/

Linkedin: https://www.linkedin.com/in/touraj-manshadi

Please like, subscribe, and comment on our podcasts!

Please consider making a donation: https://thebonnellfoundation.org/donate/

The Bonnell Foundation website:https://thebonnellfoundation.org

Email us at: thebonnellfoundation@gmail.com

Thanks to our sponsors:

Vertex: https://www.vrtx.com

Viatris: https://www.viatris.com/en

  continue reading

139集单集

Artwork
icon分享
 
Manage episode 445063602 series 2902409
内容由The Bonnell Foundation and Laura Bonnell提供。所有播客内容(包括剧集、图形和播客描述)均由 The Bonnell Foundation and Laura Bonnell 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

We’re in Canada for this podcast. Canadian Advocate Beth Vanstone has two daughters, one with CF and she’s hosting this podcast with Laura Bonnell.

Beth is introducing us to 32-year-old To Touraj Dehghan Manshadi who has a CF mutation that is common to Iran, but rare in Canada where he lives. You may be surprised to learn Canada does not have a rare disease strategy. We know American’s thinking that medically everything is better in Canada, but that’s not true. Many countries around the globe are struggling with the high cost of drugs for Rare Diseases, Canada is no exception. However, while we see industrialized countries around world looking at solutions to get rare therapies to patients quickly in an effort to maintain, improve and save lives, Canada remains stuck relying on a drug system designed to handle aspirin. Canada is the only country in the G7 without a national approach to rare diseases.

In February 2023 the Federal government announced a Rare Disease Drug Strategy with a 1.4 billion budget over three yrs to support it. The expectation was that drugs for rare diseases would have a quicker pathway and that it would address the specific challenges of the rare community and fill some of the many gaps to access. Sadly, that has not been the case thus far.

Beth says, “There are a lot of challenges for patients, it’s very timely, there are a lot of gaps that will potentially harm patients.” Touraj is one of the patients falling through the gaps.

Touraj says his FEV1 is 35 percent, which means he is potentially looking at a double lung transplant. “It is shocking that in the next two to three years I might be getting to the point of needing a transplant. We’re sad about it. My girlfriend is sadder about it than I am right now. I think of it as more of a reality.” The hope would be access to a drug, despite his rare mutation, but the ability to try it.

To connect with Touraj

Instagram: https://www.instagram.com/tojyla/

Facebook: https://www.facebook.com/touraj.dehghan/

Linkedin: https://www.linkedin.com/in/touraj-manshadi

Please like, subscribe, and comment on our podcasts!

Please consider making a donation: https://thebonnellfoundation.org/donate/

The Bonnell Foundation website:https://thebonnellfoundation.org

Email us at: thebonnellfoundation@gmail.com

Thanks to our sponsors:

Vertex: https://www.vrtx.com

Viatris: https://www.viatris.com/en

  continue reading

139集单集

Tous les épisodes

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南